Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mordechai Muszkat

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Pharmacology|November 11, 2011
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriersLiat Mlynarsky, Idit Bejarano-Achache, Mordechai Muszkat, et al.
Clinical Therapeutics|June 20, 2007
Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactionsMordechai Muszkat, Simcha Blotnik, Amir Elami, et al.
The Israel Medical Association Journal : IMAJ|March 13, 2018
Challenges in the Diagnosis of Cytomegalovirus Colitis in a Presumed Immunocompetent Patient: Interpretation of Clinical Condition, Tissue, and Serum Cytomegalovirus Polymerase Chain Reaction FindingsOren Yagel, Sarah Israel, Mordechai Muszkat, et al.
Molecular Diagnosis & Therapy|November 24, 2016
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy SubjectsChanan Shaul, Simcha Blotnick, Mordechai Muszkat, et al.
Pharmacogenetics and Genomics|August 28, 2015
Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamineDotan Yogev, Maamoun Basheer, Simcha Blotnick, et al.
The Canadian Journal of Cardiology|November 9, 2018
Managing Direct Oral Anticoagulants in Patients With Antiepileptic MedicationGil Dagan, Amichai Perlman, Sarit Hochberg-Klein, et al.
BMC Pharmacology & Toxicology|July 1, 2020
The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: a nested case-control studyAyala Hirsch, Maor Wanounou, Amichai Perlman, et al.
Frontiers in Endocrinology|May 28, 2020
Fasting-Induced Natriuresis and SGLT: A New Hypothesis for an Old EnigmaSamuel N Heyman, Michael Bursztyn, Auryan Szalat, et al.
Scientific Reports|November 24, 2021
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysisVictoria Rotshild, Bruria Hirsh-Raccah, Ian Miskin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 1, 2021
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial FibrillationBruria Hirsh Raccah, Yevgeni Erlichman, Arthur Pollak, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|November 11, 2011
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriersLiat Mlynarsky, Idit Bejarano-Achache, Mordechai Muszkat, et al.
Clinical Therapeutics|June 20, 2007
Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactionsMordechai Muszkat, Simcha Blotnik, Amir Elami, et al.
The Israel Medical Association Journal : IMAJ|March 13, 2018
Challenges in the Diagnosis of Cytomegalovirus Colitis in a Presumed Immunocompetent Patient: Interpretation of Clinical Condition, Tissue, and Serum Cytomegalovirus Polymerase Chain Reaction FindingsOren Yagel, Sarah Israel, Mordechai Muszkat, et al.
Molecular Diagnosis & Therapy|November 24, 2016
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy SubjectsChanan Shaul, Simcha Blotnick, Mordechai Muszkat, et al.
Pharmacogenetics and Genomics|August 28, 2015
Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamineDotan Yogev, Maamoun Basheer, Simcha Blotnick, et al.
The Canadian Journal of Cardiology|November 9, 2018
Managing Direct Oral Anticoagulants in Patients With Antiepileptic MedicationGil Dagan, Amichai Perlman, Sarit Hochberg-Klein, et al.
BMC Pharmacology & Toxicology|July 1, 2020
The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: a nested case-control studyAyala Hirsch, Maor Wanounou, Amichai Perlman, et al.
Frontiers in Endocrinology|May 28, 2020
Fasting-Induced Natriuresis and SGLT: A New Hypothesis for an Old EnigmaSamuel N Heyman, Michael Bursztyn, Auryan Szalat, et al.
Scientific Reports|November 24, 2021
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysisVictoria Rotshild, Bruria Hirsh-Raccah, Ian Miskin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 1, 2021
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial FibrillationBruria Hirsh Raccah, Yevgeni Erlichman, Arthur Pollak, et al.
Pageof 8